AnaptysBio's Grant

AnaptysBio raised a round of funding on October 17, 2009. Investors include Qualifying Therapeutic Discovery Project.

AnaptysBio is a privately-held company focused on the generation of antibody therapeutics and is the leader in the use of somatic hypermutation (SHM) for antibody discovery and optimization. The compa…

Articles about AnaptysBio's Grant: